<DOC>
	<DOCNO>NCT00197821</DOCNO>
	<brief_summary>To compare relative immunogenicity reactogenicity exist 23 valent plain pneumococcal vaccine 7 valent pneumococcal conjugate vaccine healthy UK adult age 50-80 year , subsequent antibody persistence response boosting .</brief_summary>
	<brief_title>Evaluation Immunogenicity Reactogenicity Pneumococcal Conjugate Vaccine Healthy Adults</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Written inform consent participation study ; age 50 80 year recruitment Lack adequate comprehension information sheet , consent form study nurse 's explanation study order give inform consent . Current participation clinical trial Any vaccination previous month ( except influenza vaccination give time study ) Prior pneumococcal conjugate vaccine ( PNC ) 23 valent pneumococcal vaccine ( PPV ) last 5 year Severe general local reaction previous dose PNC PPV Patients currently immunocompromised list UK Handbook `` Immunisation Against Infectious Disease '' ed 1996 Patients receive intravenous immunoglobulin previous month require replacement intravenous immunoglobulin period study Patients pneumococcal vaccination ( PPV ) currently recommend per UK Handbook `` Immunisation Against Infectious Disease '' Deferral vaccination acute systemic illness temperature &gt; 38C day vaccination</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>